Experimental allergic encephalitis: Study of cellular immunity during disease suppression (Q39519171)

12 September 2017

Experimental allergic encephalitis: Study of cellular immunity during disease suppression (English)

1 reference

https://api.crossref.org/works/10.1002/EJI.1830081104

8 November 2022

1 reference

cell-mediated immunity

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A82509

8 November 2022

immunosuppression

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A82509

8 November 2022

1 reference

https://api.crossref.org/works/10.1002/EJI.1830081104

8 November 2022

author name string

von Muller CS

1

1 reference

12 September 2017

LeCocq J

3

1 reference

12 September 2017

C. S. von Muller

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A82509

8 November 2022

L. E. Spitler

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A82509

8 November 2022

J. LeCocq

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A82509

8 November 2022

language of work or name

English

0 references

publication date

1 November 1978

1 reference

full work available at URL

12 September 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Feji.1830081104

1 reference

https://api.crossref.org/works/10.1002/EJI.1830081104

https://onlinelibrary.wiley.com/doi/full/10.1002/eji.1830081104

8 November 2022

1 reference

https://api.crossref.org/works/10.1002/EJI.1830081104

European Journal of Immunology

8 November 2022

published in

1 reference

12 September 2017

8

1 reference

12 September 2017

11

1 reference

12 September 2017

771-776

1 reference

Myelin basic protein administration in multiple sclerosis

12 September 2017

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830081104

Suppression of acute and chronic experimental allergic encephalomyelitis in Strain 13 guinea pigs. A clinical and pathological study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830081104

7 January 2021

Suppression of experimental "allergic" encephalomyelitis in guinea pigs by encephalitogenic proteins extracted from homologous brain

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830081104

7 January 2021

ENCEPHALITOGEN-INDUCED INHIBITION OF EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS: PREVENTION, SUPPRESSION AND THERAPY.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830081104

7 January 2021

EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS: PROTECTION EXPERIMENTS WITH ENCEPHALITOGENIC FACTOR AND TUBERCLE FRACTIONS

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830081104

7 January 2021

Protective action of the encephalitogen and other basic proteins in experimental allergic encephalomyelitis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830081104

7 January 2021

Suppression of experimental allergic encephalomyelitis by a synthetic polypeptide

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830081104

7 January 2021

Suppression of experimental allergic encephalomyelitis by chemically modified encephalitogen

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830081104

7 January 2021

Suppression of the Immune Response: Reversal of the Disease State with Antigen in Allergic Encephalomyelitis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830081104

7 January 2021

Suppression by several synthetic polypeptides of experimental allergic encephalomyelitis induced in guinea pigs and rabbits with bovine and human basic encephalitogen

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830081104

7 January 2021

Experimental allergic encephalitis. Dissociation of cellular immunity to brain protein and disease production

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830081104

7 January 2021

Failure of basic protein therapy for multiple sclerosis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830081104

7 January 2021

Experimental allergic encephalomyelitis. An encephalitogenic basic protein from bovine myelin

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830081104

7 January 2021

Critique of experimental trials of therapy in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830081104

7 January 2021

Biological expressions of lymphocyte activation. II. Generation of a population of thymus-derived suppressor lymphocytes

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830081104

7 January 2021

Inhibitory and stimulatory effects of concanavalin A on the response of mouse spleen cell suspensions to antigen. I. Characterization of the inhibitory cell activity

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830081104

7 January 2021

Biological expressions of lymphocyte activation : I. Effects of phytomitogens on antibody synthesis in vitro

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830081104

7 January 2021

Specific depression of delayed hypersensitivity to purified proteins, with relation to production of circulating antibody

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830081104

7 January 2021

Cell-to-cell interaction in the immune response. X. T-cell-dependent suppression in tolerant mice

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830081104

7 January 2021

Identifiers

1 reference

12 September 2017

1 reference